A medical device importer may have a confirmed hospital order, a shipment ready for dispatch and complete customs documents, yet the consignment can still be delayed if the product is not covered under a valid CDSCO import licence.
This usually happens when the device classification is incorrect, the foreign manufacturing address does not match across documents, the Power of Attorney is incomplete or the application does not cover all product models. Even a small mismatch in the company name, manufacturing site or device description can result in an official query.
For an importer, a regulatory delay can lead to customs storage charges, cancelled purchase orders and postponed product launches. For a manufacturer, an incorrect application can delay commercial production, distributor appointments and hospital supplies.
The CDSCO licence process should therefore begin with product classification and regulatory planning, not directly with portal registration.
The Central Drugs Standard Control Organisation is India’s national regulatory authority for drugs, medical devices, in-vitro diagnostic devices, cosmetics, clinical trials and certain other healthcare products.
The expression “CDSCO certificate” is commonly used by businesses, but CDSCO does not issue one standard certificate for every product. The actual approval depends on the product, applicant type, manufacturing location, risk class and proposed business activity.
A business may require:
Medical devices are primarily regulated under the Medical Devices Rules, 2017. Cosmetics are regulated under the Cosmetics Rules, 2020. Drugs continue to be regulated under the Drugs and Cosmetics Act, 1940 and the applicable rules.
A CDSCO licence or registration may be required when a business intends to manufacture, import, test, distribute or market a regulated healthcare product in India.
Domestic medical device manufacturers generally require a manufacturing licence. The applicable form and authority depend on whether the product falls under Class A, B, C or D.
Medical device importers generally require an authorised Indian agent. The authorised agent files the application in India and remains responsible for regulatory communication, licence maintenance and product compliance.
Foreign cosmetic manufacturers can apply through an authorised Indian agent, importer or authorised Indian subsidiary. The registration must cover the manufacturing site, product categories, variants and brands proposed for import.
Businesses that commonly require CDSCO approval include:
Medical devices are divided into 4 risk classes.
| Device Class | Risk Level | General Examples | Licensing Authority |
|---|---|---|---|
| Class A | Low risk | Basic non-invasive devices | State Licensing Authority |
| Class B | Low to moderate risk | Certain diagnostic and monitoring devices | State Licensing Authority |
| Class C | Moderate to high risk | Critical diagnostic or therapeutic devices | Central Licensing Authority |
| Class D | High risk | Life-supporting or high-risk devices | Central Licensing Authority |
The classification must be based on the intended use, mode of action, invasiveness, duration of contact, sterility and measuring function.
A product should not be classified only by its commercial name. Two products with similar names may fall under different classes if their intended use or performance differs.
For example, a basic non-invasive product may fall under Class A, while a similar product intended for critical monitoring may fall under Class B or Class C.
Before filing an application, the business should confirm:
| Product or Activity | Application Form | Approval Form | Authority |
|---|---|---|---|
| Manufacture of Class A or Class B medical device | MD-3 | MD-5 | State Licensing Authority |
| Loan licence for Class A or Class B device | MD-4 | MD-6 | State Licensing Authority |
| Manufacture of Class C or Class D device | MD-7 | MD-9 | Central Licensing Authority |
| Loan licence for Class C or Class D device | MD-8 | MD-10 | Central Licensing Authority |
| Import of medical devices | MD-14 | MD-15 | Central Licensing Authority |
| Manufacture for testing or evaluation | MD-12 | MD-13 | Central Licensing Authority |
| Import for testing or evaluation | MD-16 | MD-17 | Central Licensing Authority |
| New medical device without a predicate device | MD-26 | MD-27 | Central Licensing Authority |
| New in-vitro diagnostic device | MD-28 | MD-29 | Central Licensing Authority |
| Import of cosmetics | COS-1 | COS-2 | Central Licensing Authority |
| Manufacture of cosmetics | COS-5 | COS-8 | State Licensing Authority |
| Cosmetic loan licence | COS-6 | COS-9 | State Licensing Authority |
Selecting the wrong application form can delay the project by several weeks or months because the application may need to be withdrawn, corrected and filed again.
| Regulation | Main Requirement | Timeline | Applicable To | Compliance Risk |
|---|---|---|---|---|
| Drugs and Cosmetics Act, 1940 | Regulated products must be imported or manufactured under the applicable licence | Before starting regulated activity | Drugs, devices and cosmetics | Detention, prosecution or confiscation |
| Medical Devices Rules, 2017 | Manufacturing and import licences for medical devices | Depends on device class | Manufacturers and importers | Application rejection or market delay |
| Class A manufacturing provisions | Application through Form MD-3 | Decision may be issued within 45 days | Class A manufacturers | Manufacturing delay |
| Class B audit provisions | Notified Body audit | Audit process may take up to 90 days | Class B manufacturers | Audit observations |
| Class C and Class D manufacturing provisions | Central review and inspection | Inspection stage may take around 60 days | Higher-risk manufacturers | Inspection failure |
| Medical device import provisions | Application in Form MD-14 | Decision may take up to 9 months | Importers and authorised agents | Customs and launch delay |
| Cosmetics Rules, 2020 | Import application in Form COS-1 | Decision may take up to 6 months | Cosmetic importers | Customs hold |
| Cosmetic manufacturing provisions | Application in Form COS-5 or COS-6 | Complete applications may be processed within 45 days | Cosmetic manufacturers | Production delay |
These are regulatory timelines. The total project duration may be longer if testing, legalisation, classification, technical documentation or query responses are pending.
The first step is to determine whether the product is regulated as a drug, medical device, in-vitro diagnostic device or cosmetic.
This assessment must consider the product’s intended use and claims. A product promoted only for cleansing or beautifying may fall under cosmetics. A product claiming to diagnose, treat or prevent a medical condition may fall under a different regulatory category.
Incorrect applicability assessment can affect the complete approval route.
The initial review should include:
For medical devices, the risk class determines the government fee, licensing authority, audit requirement and documentation level.
Class A and Class B manufacturing applications are generally handled by the State Licensing Authority. Class C and Class D manufacturing applications are handled by the Central Licensing Authority.
Import applications are submitted to the Central Licensing Authority, regardless of whether the device is Class A, B, C or D.
A classification note should clearly state:
A foreign medical device manufacturer generally needs an authorised Indian agent for an import licence application.
The authorised agent should hold an eligible manufacturing or wholesale licence and must be legally authorised to represent the foreign manufacturer in India.
The Power of Attorney should clearly mention:
Company names and addresses must remain consistent across the Power of Attorney, Free Sale Certificate, ISO certificate, manufacturing licence and CDSCO application.
Depending on the product and application route, businesses may need to use the SUGAM portal, medical device online portal, National Single Window System or the relevant State Drugs Licensing System.
The applicant profile should be created using the company’s official details.
Using a consultant’s personal email address or mobile number as the permanent regulatory contact can create problems when the consultant changes or the company needs to update the licence.
The portal details should match:
The application dossier is the most important part of the CDSCO licence process.
For medical devices, a product brochure is not sufficient. CDSCO may require detailed evidence covering the manufacturing process, quality controls, risk management, performance, safety and post-market compliance.
Depending on the product and risk class, the dossier may contain:
For a higher-risk device, the technical file can contain more than 15 separate regulatory sections. Missing one major section can result in an official query.
There is no single CDSCO registration fee.
The fee depends on:
The fee should be calculated only after the final product list is prepared.
For example, if 3 Class C medical devices are manufactured at one foreign site, the government fee calculation will be different from an application covering one Class A device.
The completed application is submitted with the government fee receipt and supporting documents through the relevant portal.
The business should maintain a complete submission record containing:
A separate document version register should be maintained. This prevents different versions of the Device Master File, label or Power of Attorney from being submitted during the query stage.
CDSCO may issue queries where documents are missing, inconsistent or technically insufficient.
Each query should be answered separately. A general explanation without supporting evidence may not resolve the observation.
A structured query response should contain:
The company should avoid uploading incomplete responses merely to meet an internal deadline. A weak query response can create a second query and extend the approval timeline.
Audit and inspection requirements depend on the device class and application route.
Class A manufacturers generally do not require a pre-grant audit. However, an audit may be conducted after the licence is granted.
For Class B devices, the manufacturing facility may be audited by a registered Notified Body. The audit reviews the Quality Management System, production controls, technical personnel, testing arrangements and documentation.
Class C and Class D manufacturing facilities are subject to a higher level of regulatory review and inspection.
Before an inspection, the manufacturer should verify:
After the licence is granted, the company should carefully verify the approved details.
The licence should correctly mention:
An error in the approved scope should be addressed before commercial import or production begins.
A medical device import licence application is generally submitted in Form MD-14. After approval, the licence is issued in Form MD-15.
A company importing 10 models should not assume that one Device Master File will automatically cover all models. The applicant must justify the grouping based on intended use, design, technology and risk.
A domestic manufacturer must prove that both the product and manufacturing facility comply with the applicable requirements.
The standard application file may include:
For Class B, C and D devices, audit or inspection readiness is equally important as document submission.
Cosmetic import registration is generally filed in Form COS-1. The approval is issued in Form COS-2.
The application may include:
The same product name should be used across the Free Sale Certificate, composition sheet, product list and label.
| Application Type | Site Fee | Device Fee |
|---|---|---|
| Class A or Class B domestic manufacturing | ₹5,000 | ₹500 per distinct device |
| Class C or Class D domestic manufacturing | ₹50,000 | ₹1,000 per distinct device |
| Class A non-IVD import | US$1,000 | US$50 per distinct device |
| Class B non-IVD import | US$2,000 | US$1,000 per distinct device |
| Class C or Class D non-IVD import | US$3,000 | US$1,500 per distinct device |
| Class A or Class B IVD import | US$1,000 | US$10 per distinct IVD |
| Class C or Class D IVD import | US$3,000 | US$500 per distinct IVD |
| Overseas manufacturing-site inspection | US$6,000 | Not applicable |
| Import for testing or evaluation | Not applicable | US$100 per device |
These are government fees only.
Additional costs may include:
A foreign manufacturer wants to register 3 Class C medical devices manufactured at one overseas facility.
The government fee can be calculated as follows:
If CDSCO requires an overseas inspection, an additional inspection fee of US$6,000 may apply.
The total regulatory cost will therefore depend on whether an inspection, testing or additional technical evaluation is required.
| Cosmetic Application | Government Fee |
|---|---|
| Import registration for one cosmetic category | US$1,000 |
| Each additional category | US$1,000 |
| Each cosmetic variant | US$50 |
| Each manufacturing site | US$500 |
| Permission for a new cosmetic | US$500 |
| Overseas manufacturing-site inspection | US$5,000 |
| Domestic manufacturing licence for up to 10 items in one category | ₹10,000 |
| Each additional item | ₹500 |
| Additional category covering up to 10 items | ₹10,000 |
| Cosmetic loan licence covering up to 10 items | ₹10,000 |
A cosmetic importer filing 4 categories with 12 variants should calculate the fee based on categories, variants and manufacturing sites rather than paying a flat amount.
| Step | Authority | Estimated or Regulatory Timeline | Main Documents | Main Risk |
|---|---|---|---|---|
| Product classification | Applicant | 3 to 10 working days as a planning estimate | Product information | Incorrect route |
| Document collection | Applicant | 2 to 8 weeks depending on readiness | Legal and technical records | Missing documents |
| Class A manufacturing decision | State Authority | Up to 45 days | MD-3 application | Rejection |
| Class A post-grant audit | Notified Body | Within 120 days after approval | QMS records | Post-grant observations |
| Class B audit | Notified Body | Up to 90 days | Technical and QMS records | Audit delay |
| Class C and Class D inspection | Central Authority | Inspection stage may take around 60 days | Complete facility records | Inspection failure |
| Medical device import licence | Central Authority | Up to 9 months | MD-14 dossier | Product launch delay |
| Cosmetic import registration | Central Authority | Up to 6 months | COS-1 dossier | Customs hold |
| Cosmetic manufacturing licence | State Authority | Up to 45 days for a complete application | COS-5 or COS-6 | Production delay |
The 3 to 10 working-day classification period and 2 to 8 week document-preparation period are project-planning estimates. They are not guaranteed government timelines.
Medical device manufacturing and import licences generally continue to remain valid, subject to payment of the applicable retention fee after every 5-year period.
This means the licence may not require traditional renewal every 5 years, but the company must still pay the retention fee and maintain compliance.
For certain manufacturing licences, delayed payment may be accepted for a limited period with late fees. If the fee is not paid within the permitted period, the licence may be treated as cancelled.
A compliance calendar should include:
Not every Class A medical device is exempt from licensing.
The simplified registration route applies only when the device is both:
The manufacturer or importer must still complete online registration and provide prescribed product information.
The information may include:
After successful submission, the portal generates a registration number.
Incorrectly using this route for a sterile or measuring device can result in suspension, cancellation or regulatory action.
A Class C device filed as Class B may require a new application, higher government fee and additional technical documentation.
A different product name across the label, Free Sale Certificate and Device Master File can create doubts about whether the documents cover the same device.
The address on the ISO certificate, manufacturing licence and Power of Attorney should refer to the same legal manufacturing location.
A marketing brochure cannot replace a Device Master File. CDSCO expects structured technical evidence.
The Power of Attorney must correctly identify the manufacturer, Indian authorised agent, product scope and manufacturing site.
An application can be delayed where the fee does not cover all manufacturing sites or distinct devices.
A response without supporting documents, page references or revised attachments may result in a second query.
A Free Sale Certificate that expires during the review process may need to be replaced.
An incomplete or technically deficient application may be rejected. The applicant may need to correct the dossier and submit a new application.
A licence may be suspended where the manufacturer or importer does not comply with licence conditions, product standards or post-market responsibilities.
Repeated non-compliance, false information, manufacturing deviations or failure to pay retention fees may lead to cancellation.
Imported medical devices or cosmetics can be detained where the shipment is not covered under a valid approval or where the product details do not match the licence.
The authority may direct the manufacturer or importer to stop sales and recall affected products from distributors, hospitals or users.
A manufacturing facility may be required to stop production if the licence is suspended or the approved manufacturing conditions are not maintained.
Manufacturing, importing or selling regulated products without the required licence can attract penalties under the Drugs and Cosmetics Act.
Depending on the nature of the offence, consequences may include:
An Indian importer planned to introduce 3 models of an overseas diagnostic device.
The importer treated all 3 models as one Class B medical device and paid the government fee accordingly. During technical review, the authority found that one model had a different intended use and performance specification.
The Free Sale Certificate also used an abbreviated manufacturing-site name, while the ISO 13485 certificate mentioned the full legal address.
The applicant had to revise the product grouping, pay the differential government fee and obtain corrected documents from the foreign manufacturer.
The hospital launch was delayed because the licence could not be issued against an inconsistent technical and legal dossier.
The delay could have been reduced by completing the following checks before submission:
The strongest CDSCO application is one in which the legal, technical and commercial information remains consistent.
Before submission, businesses should conduct a final 10-point review:
A well-prepared application does not guarantee an immediate approval, but it significantly reduces avoidable queries and repeated document submissions.
A CDSCO licence is not a standard company registration. It is a product-specific regulatory approval based on the product category, risk classification, manufacturing location and proposed business activity.
Government fees may range from ₹500 per device for certain domestic applications to several thousand US dollars for imported higher-risk devices. Medical device import applications may take up to 9 months, while cosmetic import registration may take up to 6 months under the applicable regulatory process.
The main causes of delay are usually not the portal itself. Problems generally arise from incorrect classification, inconsistent manufacturer details, incomplete technical files, invalid legal documents and incorrect fee calculations.
Businesses planning to manufacture or import regulated healthcare products should complete classification, document reconciliation and fee calculation before filing the application.
Early preparation can reduce the risk of customs detention, product-launch delay, application rejection and commercial losses.
📞 +91 78350 06182
📧 wecare@greenpermits.in
👉 Book a Consultation with Green Permits
A CDSCO certificate is a general business term used for a licence, registration or permission issued for drugs, medical devices, cosmetics or related regulated products.
Medical device import applications are generally filed in Form MD-14. After approval, the import licence is issued in Form MD-15.
A medical device import application may take up to 9 months under the regulatory process. The actual time depends on document readiness, classification and query responses.
There is no single fee. Domestic medical device manufacturing fees can start from ₹5,000 per site plus ₹500 per device. Import fees depend on the risk class, manufacturing site and number of devices.
No. Class A devices that are both non-sterile and non-measuring may follow the simplified online registration route. Other Class A devices remain subject to licensing requirements.
